8.09 USD
▼-0.22-2.65%
盘后 7.61 0.00%
2026-09-15
市值
$475.38M
市盈率
21.50
EPS
0.38
股息率
5.13%
52 周区间
6.50 – 9.35
成交量
119.78K
Beta
0.14
目标价
13.50
52W 低 6.5052W 高 9.35
价格走势
公司简介
Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM f...